297 related articles for article (PubMed ID: 9551222)
21. [Aspects of molecular remission in hematology and oncology].
Novik AA; Kamilova TA; Tsygan VN
Vopr Onkol; 2001; 47(3):270-7. PubMed ID: 11544823
[No Abstract] [Full Text] [Related]
22. [The role of bone marrow transplantation in the treatment of leukemia].
Robak T
Przegl Lek; 1990; 47(10):723-7. PubMed ID: 2089452
[No Abstract] [Full Text] [Related]
23. The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.
Redaelli A; Stephens JM; Laskin BL; Pashos CL; Botteman MF
Expert Rev Anticancer Ther; 2003 Jun; 3(3):311-29. PubMed ID: 12820775
[TBL] [Abstract][Full Text] [Related]
24. Stat bite: Estimated new leukemia cases in 2008.
J Natl Cancer Inst; 2008 Apr; 100(8):531. PubMed ID: 18398092
[No Abstract] [Full Text] [Related]
25. Current status of vaccination therapy for leukemias.
Reichardt VL; Brossart P
Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
28. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
Mendeleeva LP
Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
[No Abstract] [Full Text] [Related]
29. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic inhibition of the Bcr-Abl kinase with STI571: a novel, safe, and effective therapy for chronic myeloid leukemia.
Press RD
Mol Diagn; 2001 Sep; 6(3):211-3. PubMed ID: 11571715
[No Abstract] [Full Text] [Related]
31. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
[No Abstract] [Full Text] [Related]
32. Drug development: target practice.
Katsnelson A
Nature; 2013 Jun; 498(7455):S8-9. PubMed ID: 23803950
[No Abstract] [Full Text] [Related]
33. [Examination of human herpesvirus-6 antibody in blood patients serum].
Wang D; Xiao Y; Luo M; Zhang X
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):198-200. PubMed ID: 11938792
[TBL] [Abstract][Full Text] [Related]
34. 2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies.
Saven A; Piro LD
Leuk Lymphoma; 1993; 10 Suppl():43-9. PubMed ID: 8097654
[No Abstract] [Full Text] [Related]
35. Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of paclitaxel.
Seiter K; Feldman EJ; Traganos F; Li X; Halicka HD; Darzynkiewicz Z; Lederman CA; Romero MB; Ahmed T
Leukemia; 1995 Nov; 9(11):1961-6. PubMed ID: 7475290
[No Abstract] [Full Text] [Related]
36. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
37. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
[TBL] [Abstract][Full Text] [Related]
38. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
39. Platelet function in acute leukemias.
Naresh KN; Sivasankaran P; Veliath AJ
J Assoc Physicians India; 1993 Jun; 41(6):377-8. PubMed ID: 8005978
[TBL] [Abstract][Full Text] [Related]
40. Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage.
Chaidos A; Kanfer E; Apperley JF
Best Pract Res Clin Haematol; 2007 Jun; 20(2):125-54. PubMed ID: 17448953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]